Paul G Farnham

Summary

Affiliation: Centers for Disease Control and Prevention
Country: USA

Publications

  1. pmc Cost-effectiveness of HIV screening in STD clinics, emergency departments, and inpatient units: a model-based analysis
    Vimalanand S Prabhu
    Division of Global HIV AIDS, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America
    PLoS ONE 6:e19936. 2011
  2. doi request reprint How much should we pay for a new HIV diagnosis? A mathematical model of HIV screening in US clinical settings
    Paul G Farnham
    Division of HIV AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Med Decis Making 32:459-69. 2012
  3. pmc Comparing the costs of HIV screening strategies and technologies in health-care settings
    Paul G Farnham
    Division of HIV AIDS Prevention, National Center for HIV AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, 1600 Clifton Rd NE, MS E 48, Atlanta, GA 30333, USA
    Public Health Rep 123:51-62. 2008
  4. doi request reprint Do reduced inpatient costs associated with highly active antiretroviral therapy (HAART) balance the overall cost for HIV treatment?
    Paul G Farnham
    Division of HIV AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Appl Health Econ Health Policy 8:75-88. 2010
  5. ncbi request reprint Updated estimates of healthcare utilization and costs among perinatally HIV-infected children
    Stephanie L Sansom
    Epidemiology Branch, Division of HIV AIDS Prevention, National Center for HIV, STD and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    J Acquir Immune Defic Syndr 41:521-6. 2006
  6. doi request reprint Updates of lifetime costs of care and quality-of-life estimates for HIV-infected persons in the United States: late versus early diagnosis and entry into care
    Paul G Farnham
    Division of HIV AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, GA Atlanta Veterans Affairs Medical Center, Atlanta, GA Emory University School of Medicine, Atlanta, GA and Emory University Rollins School of Public Health, Atlanta, GA
    J Acquir Immune Defic Syndr 64:183-9. 2013
  7. pmc Cost-effectiveness of pooled nucleic acid amplification testing for acute HIV infection after third-generation HIV antibody screening and rapid testing in the United States: a comparison of three public health settings
    Angela B Hutchinson
    Division of HIV AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
    PLoS Med 7:e1000342. 2010
  8. doi request reprint Emergency department HIV screening with rapid tests: a cost comparison of alternative models
    Angela B Hutchinson
    Division of HIV AIDS Prevention, National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention, 1600 Clifton Rd NE, Atlanta, GA 30333, USA
    AIDS Educ Prev 23:58-69. 2011
  9. doi request reprint Costs and outcomes of laboratory diagnostic algorithms for the detection of HIV
    Angela B Hutchinson
    Centers for Disease Control and Prevention, Atlanta, GA, United States Electronic address
    J Clin Virol 58:e2-7. 2013
  10. doi request reprint Return on public health investment: CDC's Expanded HIV Testing Initiative
    Angela B Hutchinson
    Division of HIV AIDS Prevention, National Center for HIV, Viral Hepatitis, Sexually Transmitted Disease, and Tuberculosis Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA
    J Acquir Immune Defic Syndr 59:281-6. 2012

Detail Information

Publications15

  1. pmc Cost-effectiveness of HIV screening in STD clinics, emergency departments, and inpatient units: a model-based analysis
    Vimalanand S Prabhu
    Division of Global HIV AIDS, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America
    PLoS ONE 6:e19936. 2011
    ....
  2. doi request reprint How much should we pay for a new HIV diagnosis? A mathematical model of HIV screening in US clinical settings
    Paul G Farnham
    Division of HIV AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Med Decis Making 32:459-69. 2012
    ..To develop a model to assist clinical setting decision makers in determining how much they can spend on human immunodeficiency virus (HIV) screening and still be cost-effective...
  3. pmc Comparing the costs of HIV screening strategies and technologies in health-care settings
    Paul G Farnham
    Division of HIV AIDS Prevention, National Center for HIV AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, 1600 Clifton Rd NE, MS E 48, Atlanta, GA 30333, USA
    Public Health Rep 123:51-62. 2008
    ..The purpose of this research was to estimate the costs of these different testing procedures and the cost per HIV-infected patient correctly receiving test results in three health-care scenarios that illustrated these policy differences...
  4. doi request reprint Do reduced inpatient costs associated with highly active antiretroviral therapy (HAART) balance the overall cost for HIV treatment?
    Paul G Farnham
    Division of HIV AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Appl Health Econ Health Policy 8:75-88. 2010
    ..Although the lifetime costs of treating a person with HIV have also increased, this treatment has resulted in substantial gains in the length and quality of life for those living with HIV...
  5. ncbi request reprint Updated estimates of healthcare utilization and costs among perinatally HIV-infected children
    Stephanie L Sansom
    Epidemiology Branch, Division of HIV AIDS Prevention, National Center for HIV, STD and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    J Acquir Immune Defic Syndr 41:521-6. 2006
    ..This study examined changes in healthcare use among perinatally HIV-infected children and developed new estimates of expected lifetime treatment costs...
  6. doi request reprint Updates of lifetime costs of care and quality-of-life estimates for HIV-infected persons in the United States: late versus early diagnosis and entry into care
    Paul G Farnham
    Division of HIV AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, GA Atlanta Veterans Affairs Medical Center, Atlanta, GA Emory University School of Medicine, Atlanta, GA and Emory University Rollins School of Public Health, Atlanta, GA
    J Acquir Immune Defic Syndr 64:183-9. 2013
    ..Updated estimates were used to analyze the effects of late versus early diagnosis/entry on US lifetime care costs, quality-of-life estimates, and HIV transmissions...
  7. pmc Cost-effectiveness of pooled nucleic acid amplification testing for acute HIV infection after third-generation HIV antibody screening and rapid testing in the United States: a comparison of three public health settings
    Angela B Hutchinson
    Division of HIV AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
    PLoS Med 7:e1000342. 2010
    ..However, cost-effectiveness analyses to guide policy around AHI screening are lacking; particularly after more sensitive third-generation antibody screening and rapid testing...
  8. doi request reprint Emergency department HIV screening with rapid tests: a cost comparison of alternative models
    Angela B Hutchinson
    Division of HIV AIDS Prevention, National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention, 1600 Clifton Rd NE, Atlanta, GA 30333, USA
    AIDS Educ Prev 23:58-69. 2011
    ..Our findings suggest that a hybrid model should be favored over either a supplemental staff or existing staff model in terms of cost per outcome achieved...
  9. doi request reprint Costs and outcomes of laboratory diagnostic algorithms for the detection of HIV
    Angela B Hutchinson
    Centers for Disease Control and Prevention, Atlanta, GA, United States Electronic address
    J Clin Virol 58:e2-7. 2013
    ..While it promises greater sensitivity, it also raises concerns about costs...
  10. doi request reprint Return on public health investment: CDC's Expanded HIV Testing Initiative
    Angela B Hutchinson
    Division of HIV AIDS Prevention, National Center for HIV, Viral Hepatitis, Sexually Transmitted Disease, and Tuberculosis Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA
    J Acquir Immune Defic Syndr 59:281-6. 2012
    ..Policy makers, who must optimize public health given a set budget, are interested in the financial return on investment (ROI) of large-scale HIV testing...
  11. ncbi request reprint A meta-analysis of the effectiveness of alternative HIV counseling and testing methods to increase knowledge of HIV status
    Angela B Hutchinson
    Division of HIV AIDS Prevention, National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA 30306, USA
    AIDS 20:1597-604. 2006
    ..Alternatives to conventional HIV counseling and testing (HIV-CT) have been used to improve receipt of HIV test results...
  12. doi request reprint Comparison of methods for estimating the cost of human immunodeficiency virus-testing interventions
    Ram K Shrestha
    Division of HIV AIDS Prevention, National Center for HIV AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA
    J Public Health Manag Pract 18:259-67. 2012
    ..An accurate estimate of the costs of HIV testing in various settings is essential for efficient allocation of HIV prevention resources...
  13. ncbi request reprint The economic burden of HIV in the United States in the era of highly active antiretroviral therapy: evidence of continuing racial and ethnic differences
    Angela B Hutchinson
    Division of HIV AIDS Prevention, National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention CDC, 1600 Clifton Road NE, Atlanta, GA 30333, USA
    J Acquir Immune Defic Syndr 43:451-7. 2006
    ..Assessing the economic burden of HIV/AIDS can help to quantify the effect of the epidemic on a population and assist policy makers in allocating public health resources...
  14. doi request reprint Cost effectiveness of the National HIV/AIDS Strategy goal of increasing linkage to care for HIV-infected persons
    Chaitra Gopalappa
    Division of HIV AIDS Prevention, Centers for Disease Control and Prevention, 1600 Clifton Rd, NE, MS E 48, Atlanta, GA 30333, USA
    J Acquir Immune Defic Syndr 61:99-105. 2012
    ..We evaluated the cost effectiveness of achieving the NHAS goal and estimated the maximum cost that HIV programs could spend on linkage to care and remain cost effective...
  15. ncbi request reprint Human immunodeficiency virus retesting during pregnancy: costs and effectiveness in preventing perinatal transmission
    Stephanie L Sansom
    National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Obstet Gynecol 102:782-90. 2003
    ..To estimate the incremental societal costs and effectiveness of a second human immunodeficiency virus (HIV) antibody test during the third trimester of pregnancy compared with no second test...